Because the impact of WDR5 and the MYC–WDR5 interaction on target RPG transcription is around two-fold [16,62,77,82], the self-limiting nature of WINi may provide a greater margin for safety than rRNA inhibitors that have to be dosed to split the difference between ribosome addiction in normal and cancer cells. The gene discussed is WDR5; the disease is cancer.